Richard A. Young, Director at Syros Pharmaceuticals, Inc. (SYRS), sold 69,674 shares at $5.12 ($357K) on 2024-06-28, disclosed to the SEC on 2024-07-02.
Scheduled sale ($357k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.12 | 34,837 | $178K | 50.0% |
| 2 | $5.12 | 34,837 | $178K | 50.0% |
| Total | $5.12 avg | 69,674 | $357K | 100% |
| Filing → |
| OMGA | SELL | 2023-05-03 | $40K | — | Filing → |
| OMGA | SELL | 2023-04-10 | $40K | — | Filing → |
| OMGA | SELL | 2023-03-20 | $80K | — | Filing → |